Diversified science and technology conglomerate (NYSE: DHR)
Appears in 1 story
Acquirer; will integrate Masimo into Diagnostics segment
Eighteen months after activist investor Politan Capital ousted Joe Kiani from the board of the medical-device company he founded in 1989, Masimo shareholders voted to sell it to Danaher for $9.9 billion. Roughly 37 million shares favored the deal; 17,061 opposed it, and 14,035 abstained.
Updated May 31
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
